月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE（每份年报一根整柱，柱宽 = 生效期：报告期 + 4 个月起）
加载中…
获利能力 Profitability (单位：美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率（ROE） | - | 45.74% | 51.72% | 42.82% | 39.81% | 37.73% | 34.26% | 27.86% | 23.60% | 23.73% | 23.92% | 0.90% | 31.24% | 87.67% | 6575.94% | 231.06% | 162.32% | 77.62% | 42.82% | 29.27% | 13.44% | -2.34% |
| 总资产收益率（ROA） | - | 14.25% | 19.87% | 16.95% | 16.40% | 15.90% | 14.57% | 12.56% | 11.14% | 10.99% | 11.19% | 0.38% | 15.93% | 23.16% | 18.37% | 22.39% | 21.57% | 13.88% | 14.01% | 12.66% | 5.68% | -0.84% |
| 毛利率 | 58.12% | 57.16% | 58.02% | 60.31% | 60.25% | 60.54% | 59.99% | 58.86% | 58.53% | 58.74% | 58.87% | 58.99% | 58.98% | 58.00% | 57.44% | 58.49% | 58.00% | 59.57% | 59.43% | 59.28% | 58.27% | 45.40% |
| 净利率 | 17.36% | 18.20% | 20.47% | 21.57% | 23.23% | 23.39% | 25.03% | 23.63% | 21.70% | 22.97% | 24.06% | 0.88% | 24.54% | 24.61% | 22.05% | 24.87% | 23.81% | 21.72% | 21.56% | 20.30% | 18.70% | -7.14% |
| 每股收益（EPS） | 2.16 | 2.67 | 3.25 | 3.37 | 4.13 | 4.77 | 5.25 | 5.27 | 5.12 | 5.70 | 6.46 | 0.25 | 7.71 | 8.76 | 8.40 | 11.25 | 11.80 | 10.87 | 10.75 | 10.80 | 4.51 | -2.31 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 31.76% | 26.40% | 17.88% | 13.25% | 14.10% | 15.18% | 12.30% | 10.90% | 11.42% | 10.85% | 12.06% | 21.36% | 13.13% | 15.38% | 16.20% | 14.64% | 8.54% | 7.14% | 11.58% | 7.78% | 2.18% |
| 负债占总资产比率 | - | 68.84% | 59.27% | 55.50% | 54.08% | 54.96% | 53.68% | 50.79% | 51.10% | 51.77% | 50.62% | 58.05% | 57.95% | 108.46% | 91.83% | 88.12% | 84.63% | 75.14% | 59.85% | 49.54% | 54.22% | 38.61% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 4.64 | 5.40 | 4.77 | 4.59 | 5.04 | 4.56 | 4.42 | 4.59 | 4.36 | 4.43 | 4.33 | 4.26 | 4.09 | 4.13 | 4.55 | 4.11 | 4.21 | 4.03 | 3.82 | 1.96 | 1.47 |
| 平均收现日数 | - | 79 天 | 68 天 | 77 天 | 80 天 | 72 天 | 80 天 | 83 天 | 80 天 | 84 天 | 82 天 | 84 天 | 86 天 | 89 天 | 88 天 | 80 天 | 89 天 | 87 天 | 90 天 | 96 天 | 186 天 | 249 天 |
| 固定资产周转率(次) | - | 0.1092 | 0.1089 | 0.1407 | 0.1309 | 0.1281 | 0.1482 | 0.1706 | 0.1617 | 0.1632 | 0.1555 | 0.1513 | 0.1418 | 0.1734 | 0.2088 | 0.1967 | 0.1959 | 0.2162 | 0.2201 | 0.2028 | 0.4503 | 0.5113 |
| 总资产周转率 | - | 78.31% | 97.06% | 78.55% | 70.60% | 67.98% | 58.19% | 53.15% | 51.34% | 47.84% | 46.49% | 43.37% | 64.92% | 94.12% | 83.29% | 90.01% | 90.57% | 63.90% | 64.97% | 62.35% | 30.37% | 11.77% |
现金流量 Cash Flow (单位：亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 5.97 | 4.29 | 3.41 | 3.08 | 3.84 | 4.81 | 4.41 | 4.22 | 4.88 | 5.06 | 6.42 | 7.96 | 3.36 | 4.37 | 5.01 | 4.81 | 3.95 | 3.25 | 5.88 | 3.67 | 5.39 |
| 净利润 | 2.22 | 2.68 | 3.22 | 3.23 | 3.82 | 4.33 | 4.61 | 4.50 | 4.32 | 4.69 | 5.22 | 0.20 | 5.94 | 5.92 | 5.22 | 6.93 | 7.08 | 6.42 | 6.38 | 6.43 | 2.68 | -2.08 |
| 经营活动现金流量 | 2.64 | 3.71 | 4.18 | 4.18 | 4.58 | 4.97 | 4.49 | 4.85 | 5.12 | 5.73 | 6.43 | 6.98 | 6.04 | 6.43 | 7.91 | 7.47 | 6.12 | 6.03 | 7.62 | 6.53 | 3.01 | 1.98 |
| 投资活动现金流量 | -1.30 | -1.68 | 0.19 | -4.19 | -4.12 | -3.56 | -2.96 | -4.65 | -4.02 | -4.00 | -4.88 | -5.36 | 16.83 | 7.69 | -2.64 | -2.32 | -1.08 | -14.42 | -1.43 | -1.52 | -0.85 | 0.97 |
| 筹资活动现金流量 | -1.26 | -1.20 | -5.73 | -0.90 | -0.60 | -0.60 | -0.67 | -0.65 | -1.07 | -0.83 | -1.16 | -0.64 | -21.20 | -18.73 | -4.41 | -4.38 | -5.10 | 7.55 | -6.97 | -2.37 | -1.74 | -3.37 |
| 净现金流量 | 0.21 | 0.83 | -1.69 | -0.87 | -0.33 | 0.75 | 0.97 | -0.40 | -0.19 | 0.65 | 0.18 | 1.37 | 1.54 | -4.61 | 1.01 | 0.65 | -0.21 | -0.85 | -0.70 | 2.62 | 0.42 | -0.49 |
右侧两列为报告期累计口径同比（左：去年同期同一期次，右：最近一期季报，年报期次已在左侧列展示）；周转率类指标为报告期累计值，未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD